We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Feature

The Startup Drugmaker's Post-Helsinn Survival Guide

Law360 (January 25, 2019, 9:38 PM EST) -- The U.S. Supreme Court dashed the hopes of smaller pharmaceutical and biotech companies with its recent ruling that businesses can't sell unpatented inventions to other companies without risking losing their future...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.